Latest period
$250.00M
YoY change
+44.5%
5Y CAGR
-0.5%
Peak year (2019)
$294.00M
Latest annual
$276.00M
Stock-Based Compensation history chart for Elevance Health (ELV) from 2001 to 2025
Latest: $276.00M
Stock-Based Compensation growth chart for Elevance Health (ELV) from 2001 to 2025
Latest: +44.5%
Stock-Based Compensation history table for Elevance Health (ELV) from 2001 to 2025
| 2025 | $276.00M | +44.5% | +$85.00M | ||
| 2024 | $191.00M | -33.9% | −$98.00M | ||
| 2023 | $289.00M | +9.5% | +$25.00M | ||
| 2022 | $264.00M | +3.5% | +$9.00M | ||
| 2021 | $255.00M | -9.9% | −$28.00M | ||
| 2020 | $283.00M | -3.7% | −$11.00M | ||
| 2019 | $294.00M | +30.1% | +$68.00M | ||
| 2018 | $226.00M | +33.3% | +$56.40M | ||
| 2017 | $169.60M | +3.0% | +$5.00M | ||
| 2016 | $164.60M | +11.1% | +$16.40M | ||
| 2015 | $148.20M | -12.3% | −$20.70M | ||
| 2014 | $168.90M | +15.7% | +$22.90M | ||
| 2013 | $146.00M | -0.3% | −$500.00K | ||
| 2012 | $146.50M | +8.7% | +$11.70M | ||
| 2011 | $134.80M | -0.9% | −$1.20M | ||
| 2010 | $136.00M | -11.5% | −$17.60M | ||
| 2009 | $153.60M | -1.5% | −$2.40M | ||
| 2008 | $156.00M | -11.9% | −$21.10M | ||
| 2007 | $177.10M | -28.3% | −$69.80M | ||
| 2006 | $246.90M | — | +$246.90M | ||
| 2005 | $0.00 | — | $0.00 | ||
| 2004 | $0.00 | — | $0.00 | ||
| 2003 | $0.00 | — | $0.00 | ||
| 2002 | $0.00 | — | $0.00 | ||
| 2001 | $0.00 | — | — |
- 2025$276.00M+44.5%
- 2024$191.00M-33.9%
- 2023$289.00M+9.5%
- 2022$264.00M+3.5%
- 2021$255.00M-9.9%
- 2020$283.00M-3.7%
- 2019$294.00M+30.1%
- 2018$226.00M+33.3%
- 2017$169.60M+3.0%
- 2016$164.60M+11.1%
- 2015$148.20M-12.3%
- 2014$168.90M+15.7%
- 2013$146.00M-0.3%
- 2012$146.50M+8.7%
- 2011$134.80M-0.9%
- 2010$136.00M-11.5%
- 2009$153.60M-1.5%
- 2008$156.00M-11.9%
- 2007$177.10M-28.3%
- 2006$246.90M—
- 2005$0.00—
- 2004$0.00—
- 2003$0.00—
- 2002$0.00—
- 2001$0.00—
Stock-Based Compensation values are taken from Elevance Health's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Stock-Based Compensation at Elevance Health (ELV)
Stock-Based Compensation for Elevance Health (ELV): headline value $250.00M · YoY +44.5%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Elevance Health (ELV) stock-based compensation totalled $276.00M – surged 44.5% year-over-year.
Over 2020–2025 (5 years), Elevance Health stock-based compensation expanded at a -0.5% compound annual rate, with a net decline across the window.
The record annual stock-based compensation stands at $294.00M, reached in 2019; the historical low of $0.00 was recorded in 2001.
Elevance Health Stock-Based Compensation by Year
Elevance Health Stock-Based Compensation 2025: $276.00M
2025's stock-based compensation for Elevance Health came in at $276.00M, surged 44.5% from 2024.
Elevance Health Stock-Based Compensation 2024: $191.00M
Elevance Health posted stock-based compensation of $191.00M in 2024, plunged 33.9% below 2023.
Elevance Health Stock-Based Compensation 2023: $289.00M
In 2023, Elevance Health reported stock-based compensation of $289.00M, grew 9.5% from 2022.
Elevance Health Stock-Based Compensation 2022: $264.00M
Elevance Health stock-based compensation in 2022 was $264.00M, edged up 3.5% from 2021.
Elevance Health Stock-Based Compensation 2021: $255.00M
Elevance Health stock-based compensation in 2021 was $255.00M.
See more financial history for Elevance Health (ELV).
Sector peers by Stock-Based Compensation
Healthcare peers of Elevance Health (ELV), ranked by their latest stock-based compensation
| $1.35B | |
| $971.00M | |
| $955.00M | |
| $626.00M | |
| $0.00 | |
| $0.00 | |
| $0.00 | |
| $0.00 |
- $1.35B
- $971.00M
- $955.00M
- $626.00M
- $0.00
- $0.00
- $0.00
- $0.00
Frequently asked questions
Elevance Health (ELV) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation